JP2016505039A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505039A5 JP2016505039A5 JP2015553775A JP2015553775A JP2016505039A5 JP 2016505039 A5 JP2016505039 A5 JP 2016505039A5 JP 2015553775 A JP2015553775 A JP 2015553775A JP 2015553775 A JP2015553775 A JP 2015553775A JP 2016505039 A5 JP2016505039 A5 JP 2016505039A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- metformin
- glp1r agonist
- glp1r
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361753567P | 2013-01-17 | 2013-01-17 | |
| US61/753,567 | 2013-01-17 | ||
| PCT/US2014/011394 WO2014113357A1 (en) | 2013-01-17 | 2014-01-14 | Combinations of a glp1r agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505039A JP2016505039A (ja) | 2016-02-18 |
| JP2016505039A5 true JP2016505039A5 (Direct) | 2017-02-16 |
| JP6445459B2 JP6445459B2 (ja) | 2018-12-26 |
Family
ID=50030537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553775A Active JP6445459B2 (ja) | 2013-01-17 | 2014-01-14 | Ｇｌｐ１ｒアゴニストとメトホルミンの組合わせおよび２型糖尿病その他の障害の処置のためのその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150313908A1 (Direct) |
| EP (1) | EP2945618B1 (Direct) |
| JP (1) | JP6445459B2 (Direct) |
| KR (1) | KR102165434B1 (Direct) |
| CN (1) | CN104968341B (Direct) |
| AU (1) | AU2014207748B2 (Direct) |
| CA (1) | CA2896308C (Direct) |
| EA (1) | EA201591123A1 (Direct) |
| ES (1) | ES2687083T3 (Direct) |
| IL (1) | IL239714A0 (Direct) |
| MX (1) | MX366685B (Direct) |
| SG (2) | SG10201704716XA (Direct) |
| WO (1) | WO2014113357A1 (Direct) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019060653A1 (en) | 2017-09-22 | 2019-03-28 | Regeneron Pharmaceuticals, Inc. | GLP-1 RECEPTOR AGONISTS (GLUCAGON-LIKE PEPTIDE 1) AND USES THEREOF |
| EP3790549A1 (en) * | 2018-05-08 | 2021-03-17 | vTv Therapeutics LLC | Therapeutic uses of glp1r agonists |
| WO2021196949A1 (zh) * | 2020-04-01 | 2021-10-07 | 杭州中美华东制药有限公司 | 一种glp-1受体激动剂的晶型a及其制备方法 |
| JP2023528726A (ja) * | 2020-04-01 | 2023-07-06 | ハンジョウ ジョンメイ フアドン ファーマシューティカル シーオー．，エルティーディー． | Ｇｌｐ１ｒアゴニスト遊離塩基の薬学的に許容される酸塩類およびその調製法 |
| WO2022146061A1 (ko) * | 2020-12-31 | 2022-07-07 | 동국제약 주식회사 | 신규한 용출률을 나타내는 타다라필 또는 이의 약제학적으로 허용되는 염 및 두타스테리드 또는 이의 약제학적으로 허용되는 염을 포함하는 약제학적 조성물 |
| KR20250075642A (ko) | 2022-09-21 | 2025-05-28 | 리제너론 파아마슈티컬스, 인크. | 비만, 당뇨병 및 간 기능 장애를 치료하는 방법 |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4080472A (en) | 1974-03-22 | 1978-03-21 | Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. | Metformin 2-(p-chlorophenoxy)-2-methylpropionate |
| AU2006311601A1 (en) * | 2005-11-07 | 2007-05-18 | Elixir Pharmaceuticals, Inc. | Combinations of metformin and meglitinide |
| CA2716664C (en) * | 2008-03-07 | 2016-10-11 | Transtech Pharma, Inc. | Oxadiazoanthracene compounds |
| BRPI1013579A2 (pt) * | 2009-03-30 | 2020-11-03 | Transtech Pharma, Inc. | derivados de azoantraceno substituídos, composições farmacêuticas e métodos de uso dos mesmos |
| WO2011031620A1 (en) | 2009-09-11 | 2011-03-17 | Transtech Pharma, Inc. | Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| PL2554183T3 (pl) * | 2009-11-13 | 2018-10-31 | Sanofi-Aventis Deutschland Gmbh | Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę |
| US20110118180A1 (en) * | 2009-11-13 | 2011-05-19 | Sanofi-Aventis Deutschland Gmbh | Method of treatment of diabetes type 2 comprising add-on therapy to metformin |
| US20130040878A1 (en) * | 2011-05-13 | 2013-02-14 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in the treatment of diabetes type 2 patients |
-
2014
- 2014-01-14 SG SG10201704716XA patent/SG10201704716XA/en unknown
- 2014-01-14 EP EP14702159.6A patent/EP2945618B1/en active Active
- 2014-01-14 ES ES14702159.6T patent/ES2687083T3/es active Active
- 2014-01-14 AU AU2014207748A patent/AU2014207748B2/en active Active
- 2014-01-14 CN CN201480004613.0A patent/CN104968341B/zh active Active
- 2014-01-14 MX MX2015008555A patent/MX366685B/es active IP Right Grant
- 2014-01-14 WO PCT/US2014/011394 patent/WO2014113357A1/en not_active Ceased
- 2014-01-14 JP JP2015553775A patent/JP6445459B2/ja active Active
- 2014-01-14 EA EA201591123A patent/EA201591123A1/ru unknown
- 2014-01-14 SG SG11201504778UA patent/SG11201504778UA/en unknown
- 2014-01-14 CA CA2896308A patent/CA2896308C/en active Active
- 2014-01-14 KR KR1020157018661A patent/KR102165434B1/ko active Active
-
2015
- 2015-06-30 IL IL239714A patent/IL239714A0/en unknown
- 2015-07-14 US US14/799,222 patent/US20150313908A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016505039A5 (Direct) | ||
| TWI329014B (en) | Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or h3receptor antagonist/inverse agonist | |
| JP2014528474A5 (Direct) | ||
| JP2014532638A (ja) | 置換されたキナゾリノンのための経口速放性製剤 | |
| JP2015523397A5 (Direct) | ||
| JP2009542702A5 (Direct) | ||
| JP2009542699A5 (Direct) | ||
| JP2017528507A5 (Direct) | ||
| JP2023024704A (ja) | 絶食条件下でのタシメルテオンの投与 | |
| JP2016510326A5 (Direct) | ||
| JP6445459B2 (ja) | Ｇｌｐ１ｒアゴニストとメトホルミンの組合わせおよび２型糖尿病その他の障害の処置のためのその使用 | |
| JP2022031813A (ja) | １５－ｈｅｐｅを含む組成物、およびそれを用いて線維症を処置または防止する方法 | |
| JP2013541583A5 (Direct) | ||
| JP2012502103A5 (Direct) | ||
| EP4233913A3 (en) | Improved bromocriptine formulations | |
| WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
| CN104884051A (zh) | 包含吉格列汀和二甲双胍的组合药物及其制备方法 | |
| CN104667283B (zh) | 一种治疗血脂异常和动脉粥样硬化的复方药物组合 | |
| JP2014511365A5 (Direct) | ||
| JP2017509628A5 (Direct) | ||
| CN101610760A (zh) | 恶病质的治疗 | |
| US20260000632A1 (en) | Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease | |
| JP2019528290A5 (Direct) | ||
| JP2009506043A5 (Direct) | ||
| JP2020536068A5 (Direct) |